{"id":"https://openalex.org/W2199537525","doi":null,"title":"Inhibition of sequence independent DNA-binding activity of human recombinant HMGB1 protein with natural triterpenes.","display_name":"Inhibition of sequence independent DNA-binding activity of human recombinant HMGB1 protein with natural triterpenes.","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2199537525","mag":"2199537525"},"language":"en","primary_location":{"id":"mag:2199537525","doi":null,"is_oa":false,"landing_page_url":"https://www.scholarsresearchlibrary.com/articles/inhibition-of-sequence-independent-dnabinding-activity-of-humanrecombinant-hmgb1-protein-with-natural-triterpenes.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306507771","display_name":"Der pharmacia lettre","issn_l":"0975-5071","issn":["0975-5071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Der pharmacia lettre","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075589850","display_name":"Sivakumar Annadurai","orcid":"https://orcid.org/0000-0001-7807-3742","observed_orcids":["https://orcid.org/0000-0001-7807-3742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sivakumar Annadurai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7807-3742","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009358670","display_name":"Natalia F. Krynetskaia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natalia F. Krynetskaia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104037310","display_name":"Manali S. Phadke","orcid":"https://orcid.org/0009-0009-4047-9304","observed_orcids":["https://orcid.org/0009-0009-4047-9304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manali S. Phadke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036222375","display_name":"Evgeny Y. Krynetskiy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evgeny Krynetskiy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088900927","display_name":"Daniel J. Canney","orcid":"https://orcid.org/0000-0003-2717-0328","observed_orcids":["https://orcid.org/0000-0003-2717-0328"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. Canney","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2717-0328","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16390186,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"3","first_page":"432","last_page":"443"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11385","display_name":"Natural product bioactivities and synthesis","score":0.5435000061988831,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11385","display_name":"Natural product bioactivities and synthesis","score":0.5435000061988831,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12817","display_name":"Pharmacological Effects of Natural Compounds","score":0.38109999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.018699999898672104,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hmgb1","display_name":"HMGB1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dna-binding-inhibition","display_name":"DNA binding inhibition","score":0.6790000200271606},{"id":"https://openalex.org/keywords/triterpenoids","display_name":"triterpenoids","score":0.9229999780654907},{"id":"https://openalex.org/keywords/glycyrrhizin","display_name":"glycyrrhizin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/carbenoxolone","display_name":"carbenoxolone","score":0.9900000095367432},{"id":"https://openalex.org/keywords/supramolecular-aggregation","display_name":"supramolecular aggregation","score":0.8119999766349792},{"id":"https://openalex.org/keywords/protein-dna-interactions","display_name":"protein-DNA interactions","score":0.8930000066757202},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.8489999771118164},{"id":"https://openalex.org/keywords/natural-product-drug-discovery","display_name":"natural product drug discovery","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.6482282876968384},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5389512181282043},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.4824253022670746},{"id":"https://openalex.org/C183978625","wikidata":"https://www.wikidata.org/wiki/Q903596","display_name":"Electrophoretic mobility shift assay","level":4,"score":0.47808146476745605},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4650612473487854},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.44524309039115906},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4096187949180603},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4027896225452423},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.1393495798110962},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13176867365837097}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2199537525","doi":null,"is_oa":false,"landing_page_url":"https://www.scholarsresearchlibrary.com/articles/inhibition-of-sequence-independent-dnabinding-activity-of-humanrecombinant-hmgb1-protein-with-natural-triterpenes.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306507771","display_name":"Der pharmacia lettre","issn_l":"0975-5071","issn":["0975-5071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Der pharmacia lettre","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1998492578","https://openalex.org/W2045491006","https://openalex.org/W2341769195"],"related_works":["https://openalex.org/W2530757566","https://openalex.org/W2034594119","https://openalex.org/W7005969773","https://openalex.org/W2053560870","https://openalex.org/W2290830882","https://openalex.org/W2043752475","https://openalex.org/W4416685558","https://openalex.org/W2040866709","https://openalex.org/W3094485549","https://openalex.org/W2073948328"],"abstract_inverted_index":{"DNA-protein":[0,225],"interactions":[1],"regulate":[2],"pivotal":[3],"intracellular":[4],"processes":[5],"and":[6,31,66,99,135,156,227],"thus":[7],"provide":[8],"an":[9,59],"important\r\ntarget":[10],"for":[11,36],"drug":[12,37,202],"discovery":[13],"efforts.":[14],"Small":[15],"molecules":[16],"remain":[17],"ineffective":[18],"inhibitors":[19],"of":[20,23,26,34,80,86,97,106,112,125,142,187,211,217,224,232,235],"DNA":[21,146],"binding\r\nbecause":[22],"the":[24,32,84,91,139,185,205,230],"lack":[25],"adequate":[27],"high-throughput":[28],"screening":[29],"procedures,":[30],"paucity":[33],"lead\r\nmolecules":[35],"design.":[38],"High":[39],"Mobility":[40],"Group":[41],"protein":[42],"B1":[43],"(HMGB1)":[44],"is":[45],"a":[46,77,115],"nuclear":[47],"DNA-binding\r\nprotein":[48],"with":[49,128,171,200,204],"no":[50],"known":[51],"sequence":[52],"specificity":[53],"or":[54],"enzymatic":[55],"activity,":[56],"which":[57],"plays":[58],"important":[60],"role\r\nin":[61],"chemotherapy-induced":[62],"apoptosis,":[63],"tissue":[64],"regeneration,":[65],"inflammation.":[67],"The":[68,209],"natural\r\ntriterpene":[69],"glycyrrhizin":[70],"(GLA)":[71],"has":[72],"been":[73],"reported":[74],"to":[75,151,229],"be":[76],"modest":[78],"inhibitor":[79],"DNA-HMGB1\r\nbinding":[81],"interactions,":[82],"though":[83],"mechanism":[85],"inhibition":[87,181],"remained":[88],"unclear.":[89],"In":[90,184],"present":[92],"work,\r\nwe":[93],"investigated":[94],"inhibitory":[95,140,207],"effects":[96,141],"GLA":[98,155,206],"its":[100],"derivatives":[101],"(carbenoxolone":[102],"(CGA)":[103],"and\r\npotassium":[104],"salt":[105],"glycyrrhetinate":[107],"(GAK))":[108],"on":[109,145,148,160],"DNA-binding":[110],"activity":[111],"HMGB1.":[113,131],"Using":[114],"newly\r\ndeveloped":[116],"capillary":[117],"electrophoresis":[118],"mobility":[119],"shift":[120],"assay,":[121],"we":[122],"characterized":[123],"binding":[124,162,170,226],"synthetic\r\nDNA":[126],"duplexes":[127],"recombinant":[129],"human":[130,189],"Dynamic":[132],"light":[133],"scattering":[134],"fluorometric\r\nexperiments":[136],"demonstrated":[137,193,214],"that":[138,215],"these":[143],"triterpenes":[144],"binding\r\ndepended":[147],"their":[149],"ability":[150],"form":[152],"supramolecular":[153],"aggregates.":[154],"GAK":[157,178],"demonstrated\r\ninhibitory":[158],"effect":[159],"DNA-HMGB1":[161,169],"at":[163],"concentrations":[164],"exceeding":[165],"CMC":[166],"(100-150mM).":[167],"GLA\r\ninhibited":[168],"IC50":[172],"=":[173],"500":[174],"mM;":[175],"600":[176],"mM":[177],"showed":[179],"100%":[180],"of\r\nDNA-HMGB1":[182],"binding.":[183],"presence":[186],"GLA,":[188],"lung":[190],"carcinoma":[191],"cells":[192],"more\r\nthan":[194],"300-fold":[195],"increased":[196],"viability":[197],"when":[198],"treated":[199],"chemotherapeutic":[201],"cytarabine,\r\nconsistent":[203],"activity.":[208],"results":[210],"our":[212],"study":[213],"molecules\r\ncapable":[216],"forming":[218],"stable":[219],"aggregates":[220],"are":[221],"potential":[222],"modulators":[223],"open\r\navenues":[228],"development":[231],"novel":[233],"classes":[234],"physiologically":[236],"active":[237],"compounds.":[238]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}